Talking Automation in Fill/Finish and Cell & Gene Therapies with James Rorke (INTERPHEX 2023)

Published on: 

James Rorke, vice-president, operations, Steriline North America, discusses the benefits of automation in fill/finish operations.

Advertisement

James Rorke, vice-president, operations, Steriline North America, discusses the advantages of automation in fill/finish, particulary for low volume, high quaility products such as cell and gene therapies, for which minimizing product loss is crucial.

For more INTERPHEX 2023 video content, check this page for updates.